Inhibition of respiratory burst using posttranslational modification inhibitors
US5244916A · kind A · utility
9Cited by
0References
14Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jan 31, 1992 |
| Grant date | Sep 14, 1993 |
| Priority date | — |
| Expiry date | Jan 31, 2012 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to the use of posttranslational modification inhibitors, such as isoprenylation inhibitors, to inhibit activation of phagocyte NADPH oxidase and respiratory burst. Therapeutic compositions containing various inhibitors, and methods of using same, are also disclosed.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.